 |
인쇄하기
취소
|
LG Life Sciences to seek European licenses
LG Life Sciences said it has filed to the European Medicines Agency (EMEA) its biogeneric drugs, Utropin (human growth hormone) and Intermax-alpha (interferon alpha) for the first time in Korea.
The company hopes the EMEA's approval will be made available in the 4th quarter of 2005 after completion of necessary procedures, such as data review and GMP facility inspection.
As the chemical ...
The company hopes the EMEA's approval will be made available in the 4th quarter of 2005 after completion of necessary procedures, such as data review and GMP facility inspection.
As the chemical ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.